Manufacturer copay assistance · Hizentra (J1559) · CSL Behring
Reduced cost for… · Maximum benefit Up to $4,000 per calendar year · Covers Hizentra drug cost only — does not cover administration or office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Hizentra — check the full fund board.
Run a benefits estimate for Hizentra — the program's cap applies against the patient share CareCost calculates.
Yes — Hizentra Connect Co-Pay Relief from CSL Behring. Reduced cost for eligible patients. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Reduced cost for eligible patients Maximum benefit: Up to $4,000 per calendar year. Covers Hizentra drug cost only — does not cover administration or office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.